Form 4: Cardinal Health Director Receives Equity Grant

Cardinal Health Director Sheri H. Edison was granted 1,067 restricted share units, increasing her beneficial ownership to 14,848 common shares.

Summary

• Director Sheri H. Edison of Cardinal Health Inc. (CAH) received a grant of 1,067 common shares.
• The transaction occurred on November 5, 2025, with a reported price of $0, indicating a grant rather than a purchase.
• These shares are restricted share units (RSUs) that will vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs before that date.
• Following this transaction, Ms. Edison's total beneficial ownership in Cardinal Health common shares increased to 14,848.
• A Limited Power of Attorney, executed on May 5, 2025, authorizes several individuals, including James E. Barnett (who signed the Form 4), to prepare, execute, and file SEC reports on behalf of Ms. Edison.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing reports a routine equity grant to a director, which is a positive for aligning interests but does not indicate significant operational or financial news. The grant itself is a standard compensation practice.

Positives

• Increased alignment of a director's interests with shareholders through an equity grant.
• The grant of restricted share units is a common form of executive and director compensation, often tied to long-term performance and retention.

Future Outlook

The vesting schedule for the restricted share units indicates a future commitment to the company's performance through at least November 5, 2026, aligning director incentives with long-term shareholder value.

Industry Context

Equity grants to directors are a standard practice across industries, particularly in healthcare distribution and services, to align leadership incentives with company performance and shareholder returns. This filing reflects a routine compensation event for a director.

Comparison to Industry Standards

• The grant of restricted share units to a director is a common compensation practice, aligning with corporate governance best practices that emphasize equity-based incentives for long-term value creation.
• While specific comparable companies or projects are not detailed in this filing, such grants are typical for directors in large publicly traded healthcare companies like Cardinal Health, often benchmarked against peer groups in the S&P 500 or healthcare sector.

Corporate Governance

Related Party Transactions

• Grant of 1,067 restricted share units to Director Sheri H. Edison as part of her compensation package.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with long-term shareholder value through equity ownership.
• Management: Streamlined SEC reporting for the director through the Power of Attorney.

Next Steps

• Vesting of the restricted share units on November 5, 2026, or the date of the 2026 Annual Meeting of Shareholders, whichever is earlier.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director as part of their compensation. Such a transaction, while aligning director interests with shareholders, does not provide new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should continue to evaluate Cardinal Health based on its broader financial reports and market conditions.

Keywords

Cardinal Health, CAH, Sheri H. Edison, Director, Form 4, Restricted Share Units, Equity Grant, Insider Transaction, Beneficial Ownership, Compensation